TOMTEC-ARENA vs AVIEW
AI Verdict
Choose TOMTEC-ARENA if…
Choose TOMTEC-ARENA if your institution requires a highly flexible, vendor-neutral platform for advanced medical image analysis across multiple modalities and specialties, particularly in cardiology and general radiology. Its AI-powered quantification and web-based workflows are ideal for streamlining diagnostic processes and reporting for a diverse range of 2D, 3D, and 4D imaging data.
View TOMTEC-ARENA →Choose AVIEW if…
Choose AVIEW if your primary focus is on specialized AI-driven analysis of CT scans for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification. This tool excels in providing detailed, automated quantification of specific thoracic pathologies, making it ideal for dedicated lung screening programs and cardiovascular risk assessment workflows.
View AVIEW →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | TOMTEC-ARENA | AVIEW |
|---|---|---|
| Pricing | Unknown | Subscription; one-off payment |
| Deployment | On-premise | Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker) |
| FDA Status | Unknown | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AVIEWAVIEW (Tool B) demonstrates a stronger focus on unified AI automation and an integrated diagnostic ecosystem, with clinical validation showing significant reductions in case throughput and interpretation time. While TOMTEC-ARENA (Tool A) offers web-based workflows and automation, AVIEW's ability to consolidate multi-disease CT assessment into one streamlined, automated workflow suggests a more refined and impactful user experience for its target specialties.
Clinical Value
AVIEWAVIEW (Tool B) offers deep specialization and proven impact on high-stakes conditions like lung cancer, COPD, and coronary artery calcification, with clinical studies demonstrating lower likelihood of misidentifying nodules and significant reductions in interpretation time. While TOMTEC-ARENA (Tool A) provides broad advanced quantification, AVIEW's focused and validated impact on specific diseases gives it an edge in demonstrated clinical value.
Pricing & Value
TOMTEC-ARENATOMTEC-ARENA (Tool A) provides more transparent details regarding its licensing models, explicitly mentioning concurrent user licenses, tailored options, and 'small business' pricing, which suggests a more adaptable and potentially cost-effective solution for various organizational sizes. AVIEW (Tool B) offers subscription and one-off payments but lacks further detail, making Tool A's pricing structure appear more flexible and value-oriented for diverse customer needs.
Enterprise Readiness
AVIEWAVIEW (Tool B) is explicitly HIPAA compliant and has a proven track record of deployment in large-scale screening programs across multiple countries and major U.S. centers. TOMTEC-ARENA (Tool A), while offering flexible deployment, lacks explicit public statements regarding HIPAA compliance and BAA availability, which are critical for enterprise adoption.
Innovation
AVIEWAVIEW (Tool B) demonstrates a stronger innovative edge through its deep, integrated diagnostic capabilities for specific diseases, consolidating multiple screenings (lung cancer, COPD, CAC) into a single, streamlined workflow with reported significant efficiency gains. While TOMTEC-ARENA (Tool A) offers multimodality and vendor-neutrality, AVIEW's specialized AI algorithms for comprehensive disease detection and characterization from a single scan represent a more impactful advancement in diagnostic precision and workflow transformation.
Support & Docs
TOMTEC-ARENATOMTEC-ARENA (Tool A) explicitly outlines a 'premium TOMTEC service with an Up-to-Date maintenance contract' and provides evidence of detailed documentation such as 'How-To Guides' and administration manuals. AVIEW (Tool B) provides a customer service email but lacks comparable public details on its support structure or documentation in the available information.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | TOMTEC-ARENA | AVIEW |
|---|---|---|
| Name | TOMTEC-ARENA | AVIEW |
| Company | TOMTEC Imaging Systems GmbH | Coreline Soft Co. |
| Description | AI-powered, multimodality, vendor-neutral software for advanced medical image analysis, quantification, and reporting, primarily for cardiology and radiology, with web-based workflows. | Coreline Soft's AVIEW AI platform offers comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, enhancing diagnostic precision and streamlining radiology workflows. |
| Primary Specialties | Cardiology, Radiology | Cardiology, Pulmonology, Radiology |
| Key Features (Cardiology) | AI-based measurement automation and data analytics, Multimodality and vendor-neutral imaging and analysis, Advanced quantification for various medical specialties | Coronary artery calcium (CAC) scoring (Agatston, volume, mass score, risk stratification), Automated segmentation of coronary arteries |
| Key Features (Pulmonology/Oncology) | Not specified | AI-powered lung nodule detection and characterization (size, volume, type, location, Lung-RADS score), Emphysema quantification and low attenuation area (LAA) analysis, Automated segmentation of lung lobes, airways, vessels, Interstitial Lung Disease (ILD) pattern analysis (AVIEW Lung Texture) |
Videos
Demos, reviews, and walkthroughs featuring TOMTEC-ARENA and AVIEW.